Skip to content

Clinical trials

Observational Squamous Intraepithelial Lesions trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Intraepithelial Lesions Phase: Observational Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20151
20163
20181
20194
20202
20215
20223
20232
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14
Completed8
Active, not recruiting2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fujian Maternity and Child Health Hospital5
Lei Li3
Peking University People's Hospital2
AIDS Malignancy Consortium1
Catherine Vanpachterbeke1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Hospital Universitari Vall d'Hebron Research Institute1
Hospital Universitari de Bellvitge1
Laser Surgery Care1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Intraepithelial Lesions27
Uterine Cervical Neoplasms10
Papillomavirus Infections9
Uterine Cervical Dysplasia5
Acquired Immunodeficiency Syndrome3
Adenocarcinoma in Situ3
Anus Neoplasms2
Atypical Squamous Cells of the Cervix2
Recurrence2
Basal Cell Carcinoma1

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.